EBRTExternal Beam Radiation Therapy
EBRTEast Belgian Racing Team (Belgium)
EBRTEmpty Bed Retention Time (environmental science)
EBRTEmbedded Barcode Remittance Technology
EBRTElevated Body-Rotation Test
References in periodicals archive ?
This study also validated the ProCaRS five-year BFFS nomograms for LDR-brachytherapy and EBRT in an independent cohort.
Analysis of the literature revealed that risk factors for the complications of bowel injury during percutaneous SPT placement include a small capacity or thickwalled neurogenic bladder, patients with a bladder that cannot be adequately distended, history of prior abdominal/pelvic EBRT, and/or surgery.
And the researchers found that in 39 percent of patients the tumour shrunk to less than half its pretreatment size after being treated with EBRT.
Patients Adhering to Recommended Follow-Up After External Beam Radiotherapy Highest Detroit 89% Hawaii 82% San Francisco 75% Louisiana 72% Lowest Kentucky 60% Greater California 55% Seattle 46% Connecticut 44% Note: Based on a composite measure using SEER and Medicare claims data for 11,674 men aged 65 and older who were diagnosed with clinically localized prostate cancer and treated with EBRT.
Five-year cause-specific survival was 90% for patients who had no gross residual tumor when they underwent EBRT and 69% for those with gross residual disease.
50 Gy through EBRT by conventional fraction of 2 Gy/fr through parallel opposed anterior and posterior fields along with 3 fractions of HDR brachytherapy (Each of 7.
Accordingly, the indications for EBRT for differentiated thyroid cancer remain poorly defined," said Dr.
In terms of urinary function, radical prostatectomy was worse than EBRT for the entire followup period, with 11% of men in the radical prostatectomy group and 3% of men in the EBRT remaining incontinent at 2 years.
Three factors that place brachytherapy ahead of EBRT as a popular treatment option are dose distribution, dose rate, and total dose administered
John Powers, President and CEO of IntraOp, stated, "Interest by prospective customers and users continues to increase in the Mobetron, our mobile electron-beam radiation therapy system, from both the IOERT and EBRT markets.
ProCaRS nomograms predicting five-year ASTRO II Phoenix biochemical failure-free survival for (A) LDR-brachytherapy only (n=4208); and (B) EBRT only (reproduced with permission from Cureus).
Pelvic EBRT was given using COBALT60 THERATRON 780C by two parallel opposed AP-PA portals or by four field techniques.